Results 141 to 150 of about 4,576,095 (337)
On the Power of Randomization in Algorithmic Mechanism Design [PDF]
Shahar Dobzinski, Shaddin Dughmi
openalex +1 more source
An Investigation Report on Auction Mechanism Design
Auctions are markets with strict regulations governing the information available to traders in the market and the possible actions they can take. Since well designed auctions achieve desirable economic outcomes, they have been widely used in solving real-
Niu, Jinzhong, Parsons, Simon
core +4 more sources
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source
Design and Experimentation of Tensegrity Jumping Robots
Jumping robots possess the capability to surmount formidable obstacles and are well-suited for navigating through complex terrain environments. However, most of the existing jumping robots face challenges in achieving stable jumping and they also have ...
Guoxin Tang, Qi Yang, Binbin Lian
doaj +1 more source
Optimal Multi-Dimensional Mechanism Design: Reducing Revenue to Welfare Maximization [PDF]
Yang Cai +2 more
openalex +1 more source
Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici +8 more
wiley +1 more source
Matching IoT Devices to the Fog Service Providers: A Mechanism Design Perspective. [PDF]
Bandyopadhyay A +5 more
europepmc +1 more source
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source

